MIM
TSVT

MetLife Investment Management’s 2seventy bio TSVT Stock Holding History

MetLife Investment Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,258
Closed -$145K – 2928
2025
Q1 		$145K Buy
29,258
+8,291
+40% +$26.3K ﹤0.01% 2365
2024
Q4 		$61.6K Sell
20,967
-8,692
-29% -$35.7K ﹤0.01% 2723
2024
Q3 		$140K Hold
29,659
– – ﹤0.01% 2468
2024
Q2 		$114K Buy
29,659
+12,938
+77% +$58.3K ﹤0.01% 2543
2024
Q1 		$89.5K Sell
16,721
-10,362
-38% -$48.7K ﹤0.01% 2585
2023
Q4 		$116K Hold
27,083
– – ﹤0.01% 2531
2023
Q3 		$106K Hold
27,083
– – ﹤0.01% 2551
2023
Q2 		$274K Buy
27,083
+6,365
+31% +$67.4K ﹤0.01% 2069
2023
Q1 		$211K Hold
20,718
– – ﹤0.01% 2189
2022
Q4 		$194K Hold
20,718
– – ﹤0.01% 2261
2022
Q3 		$301K Hold
20,718
– – ﹤0.01% 2021
2022
Q2 		$273K Buy
20,718
+7,777
+60% +$106K ﹤0.01% 2084
2022
Q1 		$221K Buy
12,941
+4,776
+58% +$81K ﹤0.01% 2296
2021
Q4 		$209K Buy
+8,165
New +$255K ﹤0.01% 2025

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MetLife Investment Management's TSVT Position: Q2 2025 in Review

MetLife Investment Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 29,258 shares — an estimated $145K sold.

MetLife Investment Management first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $301K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • MetLife Investment Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • MetLife Investment Management sold 29,258 2seventy bio shares in Q2 2025, an estimated $145K.
  • MetLife Investment Management first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • MetLife Investment Management's 2seventy bio position peaked at $301K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.